LIFESTANCE HEALTH GROUP INC (LFST) Fundamental Analysis & Valuation

NASDAQ:LFST • US53228F1012

Current stock price

6.89 USD
+0.22 (+3.3%)
At close:
6.89 USD
0 (0%)
After Hours:

This LFST fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LFST Profitability Analysis

1.1 Basic Checks

  • LFST had positive earnings in the past year.
  • In the past year LFST had a positive cash flow from operations.
  • In the past 5 years LFST reported 4 times negative net income.
  • LFST had a positive operating cash flow in 4 of the past 5 years.
LFST Yearly Net Income VS EBIT VS OCF VS FCFLFST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • LFST's Return On Assets of 0.44% is in line compared to the rest of the industry. LFST outperforms 48.00% of its industry peers.
  • LFST has a Return On Equity (0.64%) which is comparable to the rest of the industry.
  • LFST has a worse Return On Invested Capital (0.97%) than 62.00% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROIC 0.97%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
LFST Yearly ROA, ROE, ROICLFST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin of LFST (0.68%) is comparable to the rest of the industry.
  • With a Operating Margin value of 1.70%, LFST perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
  • LFST's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.7%
PM (TTM) 0.68%
GM N/A
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LFST Yearly Profit, Operating, Gross MarginsLFST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

5

2. LFST Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFST is destroying value.
  • LFST has more shares outstanding than it did 1 year ago.
  • LFST has more shares outstanding than it did 5 years ago.
  • LFST has a better debt/assets ratio than last year.
LFST Yearly Shares OutstandingLFST Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
LFST Yearly Total Debt VS Total AssetsLFST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.54 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.54, LFST is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • The Debt to FCF ratio of LFST is 2.55, which is a good value as it means it would take LFST, 2.55 years of fcf income to pay off all of its debts.
  • LFST has a better Debt to FCF ratio (2.55) than 71.00% of its industry peers.
  • A Debt/Equity ratio of 0.17 indicates that LFST is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.17, LFST is doing good in the industry, outperforming 71.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Altman-Z 2.54
ROIC/WACC0.11
WACC8.76%
LFST Yearly LT Debt VS Equity VS FCFLFST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • LFST has a Current Ratio of 1.65. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
  • LFST has a better Current ratio (1.65) than 66.00% of its industry peers.
  • A Quick Ratio of 1.65 indicates that LFST should not have too much problems paying its short term obligations.
  • LFST has a Quick ratio of 1.65. This is in the better half of the industry: LFST outperforms 67.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
LFST Yearly Current Assets VS Current LiabilitesLFST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. LFST Growth Analysis

3.1 Past

  • LFST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.50%, which is quite impressive.
  • Looking at the last year, LFST shows a quite strong growth in Revenue. The Revenue has grown by 13.85% in the last year.
  • Measured over the past years, LFST shows a very strong growth in Revenue. The Revenue has been growing by 30.44% on average per year.
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 134.65% on average over the next years. This is a very strong growth
  • LFST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.35% yearly.
EPS Next Y240.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue Next Year15.26%
Revenue Next 2Y14.64%
Revenue Next 3Y14.35%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFST Yearly Revenue VS EstimatesLFST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
LFST Yearly EPS VS EstimatesLFST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

2

4. LFST Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 344.50, LFST can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as LFST.
  • When comparing the Price/Earnings ratio of LFST to the average of the S&P500 Index (27.87), we can say LFST is valued expensively.
  • Based on the Price/Forward Earnings ratio of 101.32, the valuation of LFST can be described as expensive.
  • Based on the Price/Forward Earnings ratio, LFST is valued a bit more expensive than 63.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of LFST to the average of the S&P500 Index (38.51), we can say LFST is valued expensively.
Industry RankSector Rank
PE 344.5
Fwd PE 101.32
LFST Price Earnings VS Forward Price EarningsLFST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • LFST's Enterprise Value to EBITDA ratio is in line with the industry average.
  • LFST's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 24.41
EV/EBITDA 33.35
LFST Per share dataLFST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • LFST's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LFST's earnings are expected to grow with 134.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.44
PEG (5Y)N/A
EPS Next 2Y186.93%
EPS Next 3Y134.65%

0

5. LFST Dividend Analysis

5.1 Amount

  • LFST does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LFST Fundamentals: All Metrics, Ratios and Statistics

LIFESTANCE HEALTH GROUP INC

NASDAQ:LFST (4/17/2026, 8:26:11 PM)

After market: 6.89 0 (0%)

6.89

+0.22 (+3.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners42.96%
Inst Owner Change0.04%
Ins Owners3.26%
Ins Owner Change1.32%
Market Cap2.69B
Revenue(TTM)1.42B
Net Income(TTM)9.66M
Analysts82.35
Price Target9.92 (43.98%)
Short Float %4.39%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)980.59%
Min EPS beat(2)100%
Max EPS beat(2)1861.18%
EPS beat(4)4
Avg EPS beat(4)532.13%
Min EPS beat(4)67.32%
Max EPS beat(4)1861.18%
EPS beat(8)8
Avg EPS beat(8)286.19%
EPS beat(12)9
Avg EPS beat(12)177.02%
EPS beat(16)11
Avg EPS beat(16)131.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.06%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)0.3%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)0.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.33%
Revenue beat(16)8
Avg Revenue beat(16)0.11%
PT rev (1m)9.37%
PT rev (3m)12.72%
EPS NQ rev (1m)-33.3%
EPS NQ rev (3m)33.4%
EPS NY rev (1m)17.65%
EPS NY rev (3m)60%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 344.5
Fwd PE 101.32
P/S 1.89
P/FCF 24.41
P/OCF 18.38
P/B 1.77
P/tB 53.71
EV/EBITDA 33.35
EPS(TTM)0.02
EY0.29%
EPS(NY)0.07
Fwd EY0.99%
FCF(TTM)0.28
FCFY4.1%
OCF(TTM)0.37
OCFY5.44%
SpS3.65
BVpS3.9
TBVpS0.13
PEG (NY)1.44
PEG (5Y)N/A
Graham Number1.32514 (-80.77%)
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 0.64%
ROCE 1.24%
ROIC 0.97%
ROICexc 1.11%
ROICexgc 8.12%
OM 1.7%
PM (TTM) 0.68%
GM N/A
FCFM 7.73%
ROA(3y)-3.7%
ROA(5y)-7.77%
ROE(3y)-5.46%
ROE(5y)-10.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-21.84%
ROICexc growth 3YN/A
ROICexc growth 5Y6.17%
OM growth 3YN/A
OM growth 5Y-16.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.55
Debt/EBITDA 3.37
Cap/Depr 65.98%
Cap/Sales 2.54%
Interest Coverage 1.36
Cash Conversion 185.23%
Profit Quality 1138.63%
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z 2.54
F-Score8
WACC8.76%
ROIC/WACC0.11
Cap/Depr(3y)48.92%
Cap/Depr(5y)87.16%
Cap/Sales(3y)2.7%
Cap/Sales(5y)6.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y240.02%
EPS Next 2Y186.93%
EPS Next 3Y134.65%
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y18.34%
Revenue growth 5Y30.44%
Sales Q2Q%17.43%
Revenue Next Year15.26%
Revenue Next 2Y14.64%
Revenue Next 3Y14.35%
Revenue Next 5YN/A
EBIT growth 1Y175.64%
EBIT growth 3YN/A
EBIT growth 5Y9.27%
EBIT Next Year1867.82%
EBIT Next 3Y209.01%
EBIT Next 5YN/A
FCF growth 1Y28.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.26%
OCF growth 3Y40.42%
OCF growth 5YN/A

LIFESTANCE HEALTH GROUP INC / LFST Fundamental Analysis FAQ

What is the fundamental rating for LFST stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFST.


Can you provide the valuation status for LIFESTANCE HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.


How profitable is LIFESTANCE HEALTH GROUP INC (LFST) stock?

LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 2 / 10.


What is the financial health of LIFESTANCE HEALTH GROUP INC (LFST) stock?

The financial health rating of LIFESTANCE HEALTH GROUP INC (LFST) is 5 / 10.